Luminex offers the following three types of instruments:
All three xMAP®-based instruments run multiplexed assays for both proteins and nucleic acids, whether kit-based or lab-developed.
Luminex also offers a variety of reagents and accessories to suit the needs of research, clinical and applied markets.
Luminex features the following clinical tests:
xTAG® Gastrointestinal Pathogen Panel (GPP)
xTAG® GPP1 is a multiplexed nucleic acid test intended for the simultaneous qualitative detection and identification of multiple viral, parasitic, and bacterial nucleic acids in human stool specimens from individuals with signs and symptoms of infectious colitis or gastroenteritis.
NxTAG® RESPIRATORY PATHOGEN PANEL (RPP)
NxTAG® RPP enables your laboratory to simultaneously detect 20 respiratory pathogens in a single closed tube system and accommodates the higher throughput required to respond to changes in demand.
xTAG® CYP2D6 Kit v3
Simplify the complexity of CYP2D6 genotyping with the FDA-cleared in vitro diagnostic test that detects important CYP2D6 nucle
otide variants including gene deletion and gene duplication. Identify individuals with CYP2D6 polymorphisms across different populations. Obtain unambiguous calls for all samples automatically with xTAG® Data Analysis Software.
xTAG® CYP2C19 Kit v3
The xTAG® CYP2C19 Kit v3 solution offers the ability to identify CYP2C19*2 and CYP2C19*3 variants, which together account for approximately 99% of Asian and 87% of Caucasians poor metabolizers.
xTAG Cystic Fibrosis Assays
xTAG Cystic Fibrosis IVD assays are designed to detect and identify the most common CFTR mutations and variants. They offer the ability to test for the 23 CFTR mutations recommended by the American College of Medical Genetics/American College of Obstetricians and Gynecologists (ACMG/ACOG), as well as the flexibility to use an expanded panel of CF mutations to obtain broad ethnic coverage across populations.
Key applications include:
· Infectious disease testing
· Genetic testing.